THE ONE THING
Proven healthcare funds are leaving the sector in a cluster
By Cathy · Lead Analyst, Fundprints
Three large healthcare names, Bristol-Myers Squibb, Boston Scientific, and Pfizer, all turned late-stage in the same week, a cluster departure that is relatively rare in our record. Retail headlines are asking whether BMY looks cheap at 9.4x forward earnings, but funds with a proven record in the sector appear to have already answered that question for themselves…
The historical echo — what happened the last time this setup appeared — is in the full memo.
THE STORYLINES
Healthcare's proven funds exit BMY, BSX, and PFE in one week
3 names · Healthcare · names in the full memo
Oracle and Seagate reach late-stage as cloud enthusiasm builds
2 names · Technology · names in the full memo
ALSO IN THIS EDITION
- What's not happening — the silences and price-vs-evidence divergences nobody else tracks
- The tape — all 7 Prints this week, each with its base rate and why it matters
- For your book — what this week's evidence changes for the names you hold
Read the full memo.
The storylines in full, the historical echo, every Print with its base rate, and what it means for the names you actually own. New edition every week.